These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
73 related articles for article (PubMed ID: 1656569)
1. Association of HLA-A1, -A3, and -B15 with CMV disease in cytomegalovirus IgG-positive recipients of renal allografts. Harfmann P; Dittmer R; Tenschert W; Cremaschi L; Meyer-Moldenhauer WH; Arndt R; Klosterhalfen H Transplant Proc; 1991 Oct; 23(5):2660-1. PubMed ID: 1656569 [No Abstract] [Full Text] [Related]
2. Vascular rejection of renal allografts is linked to CMV IgG, positive organ donor. Tenschert W; Dittmer R; Harfmann P; Cremaschi L; Meyer-Moldenhauer WH; Arndt R; Klosterhalfen H Transplant Proc; 1991 Oct; 23(5):2641-2. PubMed ID: 1656565 [No Abstract] [Full Text] [Related]
3. HLA-DQ3 is a probable risk factor for CMV infection in high-risk kidney transplant patients. Varga M; Rajczy K; Telkes G; Hídvégi M; Péter A; Remport A; Korbonits M; Fazakas J; Toronyi E; Sárváry E; Kóbori L; Járay J Nephrol Dial Transplant; 2008 Aug; 23(8):2673-8. PubMed ID: 18332066 [TBL] [Abstract][Full Text] [Related]
4. [Incidence and prognostic value of cytomegalovirus-specific antibodies of the IgM class in kidney transplant recipients]. Eichler C; Kaden J; May G Z Urol Nephrol; 1990 Aug; 83(8):425-9. PubMed ID: 2173294 [TBL] [Abstract][Full Text] [Related]
5. Association of cytomegalovirus infection with human leukocyte antigen genotypes in recipients after allogeneic liver transplantation. Fan J; Meng XQ; Yang MF; Zhou L; Chen XM; Hu MJ; Fan WW; Ma WH; Li LJ Hepatobiliary Pancreat Dis Int; 2006 Feb; 5(1):34-8. PubMed ID: 16481279 [TBL] [Abstract][Full Text] [Related]
6. Influence of HLA mismatching on the incidence of cytomegalovirus infection in living-related renal transplantations. Haberal M; Demirağ A; Turan M; Bilgin N; Büyükpamukçu N; Arslan G Transplant Proc; 1995 Oct; 27(5):2687-90. PubMed ID: 7482876 [No Abstract] [Full Text] [Related]
7. A prospective study of cytomegalovirus infections in 78 renal allograft recipients. Braun WE; Nankervis G; Banowsky LH; Protiva D; Biekert E; McHenry MC Proc Clin Dial Transplant Forum; 1976 Nov 19-22; 6():8-12. PubMed ID: 197584 [No Abstract] [Full Text] [Related]
8. Positive donor/recipient CMV status is not a detrimental factor for renal allograft/patient survival. Krishnan G; Vaughn WK; Capelli JP; Glass NR Transplant Proc; 1993 Feb; 25(1 Pt 2):1485-6. PubMed ID: 8382877 [No Abstract] [Full Text] [Related]
9. Association between antibody response against cytomegalovirus strain-specific glycoprotein H epitopes and HLA-DR. Ishibashi K; Tokumoto T; Shirakawa H; Hashimoto K; Kushida N; Yanagida T; Shishido K; Aikawa K; Yamaguchi O; Toma H; Tanabe K; Suzutani T Microbiol Immunol; 2009 Jul; 53(7):412-6. PubMed ID: 19563400 [TBL] [Abstract][Full Text] [Related]
10. Comments on CMV infections in renal transplant patients. Nankervis GA Yale J Biol Med; 1976 Mar; 49(1):27-8. PubMed ID: 183378 [No Abstract] [Full Text] [Related]
11. Patterns of cytomegalovirus reactivation are associated with distinct evolutive profiles of immune reconstitution after allogeneic hematopoietic stem cell transplantation. Moins-Teisserenc H; Busson M; Scieux C; Bajzik V; Cayuela JM; Clave E; de Latour RP; Agbalika F; Ribaud P; Robin M; Rocha V; Gluckman E; Charron D; Socié G; Toubert A J Infect Dis; 2008 Sep; 198(6):818-26. PubMed ID: 18666855 [TBL] [Abstract][Full Text] [Related]
12. Cytomegalovirus infections in renal allograft recipients: correlative studies with histocompatibility antigens. Patel R; Fiala M; Berne V; Chatterjee N N Z Med J; 1978 Jun; 87(613):393-4. PubMed ID: 210431 [TBL] [Abstract][Full Text] [Related]
14. Cytomegalovirus disease in renal allograft recipients: a prospective study of the clinical features, risk factors and impact on renal transplantation. Peterson PK; Balfour HH; Marker SC; Fryd DS; Howard RJ; Simmons RL Medicine (Baltimore); 1980 Jul; 59(4):283-300. PubMed ID: 6248718 [TBL] [Abstract][Full Text] [Related]
15. [Detection of cytomegalovirus infection in recipients of renal transplantation]. Fan J; Qian J; He Q; Ma WH; Chen JH; Zhou L; Cai T Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2001 Sep; 15(3):262-4. PubMed ID: 11986702 [TBL] [Abstract][Full Text] [Related]
16. Transplanting kidneys from CMV-seropositive donors to CMV-seronegative recipients is not associated with poorer renal allograft function or survival. McLaughlin K; Sandhu S; Wu C; Muirhead N; Hollomby D; Jevnikar A Nephrol Dial Transplant; 2005 Jan; 20(1):176-80. PubMed ID: 15572381 [TBL] [Abstract][Full Text] [Related]
18. Human leukocyte antigens in indigenous (mapuche) people in a regional renal transplantation program in chile. Droguett MA; Oyarzún MJ; Alruiz P; Jerez V; Mezzano S; Ardiles L Transplant Proc; 2005 Oct; 37(8):3367-71. PubMed ID: 16298598 [TBL] [Abstract][Full Text] [Related]
19. An analysis of cytomegalovirus infection and HLA antigen matching on the outcome of renal transplantation. May AG; Betts RF; Freeman RB; Andrus CH Ann Surg; 1978 Feb; 187(2):110-7. PubMed ID: 204263 [TBL] [Abstract][Full Text] [Related]
20. HLA-DRB1*09 is associated with increased incidence of cytomegalovirus infection and disease after allogeneic hematopoietic stem cell transplantation. Du J; Liu J; Gu J; Zhu P Biol Blood Marrow Transplant; 2007 Dec; 13(12):1417-21. PubMed ID: 18022570 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]